Skip to main content
Bluebird Bio's N.C. manufacturing, research facility now operational
5/3/2019

The new 125,000-square-foot Bluebird Bio facility in Durham, N.C., houses about 50 researchers, engineers and employees, with more anticipated to be added. The site will manufacture the biotech firm's lentiviral vector required for the development of its gene and chimeric antigen receptor T-cell therapies, including those used for multiple myeloma treatments.

Full Story: